Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bio-Rad Laboratories stocks are traded under the ticker BUWA.MU.
When is the next Bio-Rad Laboratories earnings date?▼
Bio-Rad Laboratories is going to release the next earnings report on April 30, 2026.
What were Bio-Rad Laboratories earnings last quarter?▼
BUWA.MU earnings for the last quarter are 2.11 EUR per share, whereas the estimation was 2.28 EUR resulting in a -7.31% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Bio-Rad Laboratories have?▼
As of April 12, 2026, the company has 7,700 employees.
In which sector is Bio-Rad Laboratories located?▼
Bio-Rad Laboratories operates in the Health & Wellness sector.
When did Bio-Rad Laboratories complete a stock split?▼
Bio-Rad Laboratories has not had any recent stock splits.
Where is Bio-Rad Laboratories headquartered?▼
Bio-Rad Laboratories is headquartered in Hercules, United States.